Lubiprostone Capsule, Gelatin Coated
Product Images NDC 80425-0354

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lubiprostone (NDC 80425-0354). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 1 (Lubiprostone 8mcg 80425 0354 02)

Lubiprostone 8 mcg gelatin coated capsules, 60 count, labeled by Advanced Rx of Tennessee, LLC. The label contains storage instructions (20-25°C), a comparison reference to AMITIZA, NDC 80425-0354-02, batch and expiration details (expires 8/16/2023), and mentions Sun Pharmaceuti in Nashville, TN.*

FDA Label Image

Chemical Structure (Amitiza 01)

Chemical structure of lubiprostone showing its molecular framework with oxygen, hydrogen, carbon, and fluorine atoms, consistent with the active ingredient in the Lubiprostone 8 mcg gelatin-coated capsule by Advanced Rx of Tennessee, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.